Total Payments
$91,479
2024 Payments
$19,379
Companies
27
Transactions
119
Medicare Patients
15,221
Medicare Billing
$2.2M
Payment Breakdown by Category
Consulting$27,013 (29.5%)
Travel$22,978 (25.1%)
Other$19,102 (20.9%)
Research$18,636 (20.4%)
Food & Beverage$3,605 (3.9%)
Education$144.99 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $27,013 | 7 | 29.5% |
| Travel and Lodging | $22,978 | 12 | 25.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $19,102 | 8 | 20.9% |
| Unspecified | $18,636 | 28 | 20.4% |
| Food and Beverage | $3,605 | 62 | 3.9% |
| Education | $144.99 | 2 | 0.2% |
Payments by Type
General
$72,843
91 transactions
Research
$18,636
26 transactions
Ownership
$0
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $19,278 | 5 | $0 (2024) |
| Astellas Pharma Global Development | $18,636 | 26 | $0 (2020) |
| Avadel Specialty Pharmaceuticals, LLC | $13,412 | 9 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $9,452 | 1 | $0 (2018) |
| AMAG Pharmaceuticals, Inc. | $9,307 | 7 | $0 (2018) |
| NeoTract Inc. | $7,648 | 7 | $0 (2020) |
| Boston Scientific Corporation | $5,834 | 17 | $0 (2022) |
| PROCEPT BioRobotics Corporation | $3,067 | 13 | $0 (2022) |
| Teleflex LLC | $1,800 | 2 | $0 (2021) |
| PFIZER INC. | $1,530 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19,379 | 9 | Laborie Medical Technologies Corp. ($19,278) |
| 2023 | $494.50 | 5 | Sumitomo Pharma America, Inc. ($304.85) |
| 2022 | $2,637 | 6 | PROCEPT BioRobotics Corporation ($2,376) |
| 2021 | $2,346 | 15 | Teleflex LLC ($1,800) |
| 2020 | $9,662 | 19 | Boston Scientific Corporation ($5,419) |
| 2019 | $22,438 | 37 | Astellas Pharma Global Development ($17,886) |
| 2018 | $32,775 | 23 | Avadel Specialty Pharmaceuticals, LLC ($13,396) |
| 2017 | $1,749 | 5 | PFIZER INC. ($1,500) |
All Payment Transactions
119 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Laborie Medical Technologies Corp. | — | Travel and Lodging | Cash or cash equivalent | $11,426.33 | General |
| 06/05/2024 | Laborie Medical Technologies Corp. | — | Travel and Lodging | Cash or cash equivalent | $7,496.13 | General |
| 06/03/2024 | Laborie Medical Technologies Corp. | Optilume BPH Drug Coated Balloon Catheter (Device) | Food and Beverage | Cash or cash equivalent | $172.56 | General |
| Category: Urology | ||||||
| 05/03/2024 | SRS Medical Systems, Inc. | CT3000 Pro Base Unit (Device), UroCuff-DC Disposable, Single | Food and Beverage | Cash or cash equivalent | $69.86 | General |
| Category: Urology | ||||||
| 04/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $30.36 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/15/2024 | Laborie Medical Technologies Corp. | Optilume BPH Drug Coated Balloon Catheter (Device) | Food and Beverage | Cash or cash equivalent | $89.39 | General |
| Category: Urology | ||||||
| 02/09/2024 | Laborie Medical Technologies Corp. | Optilume BPH Drug Coated Balloon Catheter (Device) | Food and Beverage | Cash or cash equivalent | $93.89 | General |
| Category: Urology | ||||||
| 2024 | I/O Urology Corp. | — | — | — | $0.00 | Ownership |
| 2024 | I/O Urology Corp. | — | — | — | $0.00 | Ownership |
| 08/30/2023 | KOELIS Inc. | Trinity (Device) | Food and Beverage | In-kind items and services | $58.29 | General |
| Category: Urology | ||||||
| 08/29/2023 | EDAP TECHNOMED INC | — | Food and Beverage | Cash or cash equivalent | $101.00 | General |
| 06/12/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX, COMIRNATY | Food and Beverage | In-kind items and services | $30.36 | General |
| Category: ONCOLOGY | ||||||
| 04/26/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $266.15 | General |
| Category: Urology | ||||||
| 04/26/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $38.70 | General |
| Category: Urology | ||||||
| 09/30/2022 | PROCEPT BioRobotics Corporation | AQUABEAM ROBOTIC SYSTEM (Device) | Travel and Lodging | In-kind items and services | $2,347.20 | General |
| Category: Urology | ||||||
| 09/30/2022 | PROCEPT BioRobotics Corporation | AQUABEAM ROBOTIC SYSTEM (Device) | Travel and Lodging | In-kind items and services | $29.00 | General |
| Category: Urology | ||||||
| 08/16/2022 | Hollister Incorporated | VaPro (Device), Onli, Infyna Chic | Food and Beverage | Cash or cash equivalent | $14.12 | General |
| Category: Continence Care | ||||||
| 06/14/2022 | Boston Scientific Corporation | General - Therapies (Device) | Food and Beverage | In-kind items and services | $119.33 | General |
| Category: General - Therapies_URO | ||||||
| 04/11/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $18.90 | General |
| Category: Urology | ||||||
| 01/01/2022 | SRS Medical Systems, Inc. | UroCuff (Device) | Food and Beverage | Cash or cash equivalent | $108.44 | General |
| Category: Urology | ||||||
| 09/09/2021 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $31.70 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 08/17/2021 | BOSTON SCIENTIFIC CORPORATION | REZUM (Device) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: PROSTATE HEALTH | ||||||
| 08/03/2021 | BOSTON SCIENTIFIC CORPORATION | REZUM (Device) | Food and Beverage | Cash or cash equivalent | $6.71 | General |
| Category: rezum | ||||||
| 07/20/2021 | BOSTON SCIENTIFIC CORPORATION | REZUM (Device) | Food and Beverage | Cash or cash equivalent | $13.42 | General |
| Category: rezum | ||||||
| 07/01/2021 | PROCEPT BioRobotics Corporation | AQUABEAM ROBOTIC SYSTEM (Device) | Food and Beverage | In-kind items and services | $38.87 | General |
| Category: Urology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With Overactive Bladder OAB Symptoms While Taking the Alpha Blocker Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms LUTS Due to Benign Prostatic Hyperplasia BPH | Astellas Pharma Global Development | $17,417 | 22 |
| A PHASE 4, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTI-CENTER STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF MIRABEGRON IN MEN WITH OVERACTIVE BLADDER (OAB) SYMPTOMS WHILE TAKING THE ALPHA BLOCKER TAMSULOSIN HYDROCHLORIDE FOR LOWER URINARY TRACT SYMPTOMS (LUTS) DUE TO BENIGN PROSTATIC HYPERPLASIA (BPH) | Astellas Pharma Global Development | $749.84 | 3 |
| A PHASE 4, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTI-CENTER STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF MIRABEGRON IN MEN WITH OVERACTIVE BLADDER OAB SYMPTOMS WHILE TAKING THE ALPHA BLOCKER TAMSULOSIN HYDROCHLORIDE FOR LOWER URINARY TRACT SYMPTOMS LUTS DUE TO BENIGN PROSTATIC HYPERPLASIA BPH | Astellas Pharma Global Development | $469.55 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 3,862 | 4,633 | $5.2M | $506,108 |
| 2022 | 23 | 4,057 | 4,944 | $3.3M | $570,896 |
| 2021 | 31 | 4,273 | 5,469 | $3.8M | $708,576 |
| 2020 | 27 | 3,029 | 3,921 | $2.4M | $462,889 |
Total Patients
15,221
Total Services
18,967
Medicare Billing
$2.2M
Procedure Codes
102
All Medicare Procedures & Services
102 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 263 | 292 | $373,760 | $99,900 | 26.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 587 | 807 | $347,010 | $86,400 | 24.9% |
| 76705 | Limited ultrasound scan of abdomen | Office | 2023 | 653 | 877 | $324,490 | $71,666 | 22.1% |
| 0421T | Waterjet destruction of prostrate accessed through the urethra | Facility | 2023 | 52 | 52 | $520,000 | $37,336 | 7.2% |
| 51729 | Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | Office | 2023 | 96 | 96 | $133,440 | $35,094 | 26.3% |
| 55899 | Other procedure on male genital system | Office | 2023 | 109 | 118 | $2.1M | $30,817 | 1.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 130 | 134 | $134,000 | $28,432 | 21.2% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 182 | 186 | $126,840 | $23,265 | 18.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 153 | 153 | $100,980 | $20,235 | 20.0% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 96 | 96 | $62,400 | $17,742 | 28.4% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2023 | 417 | 527 | $527,000 | $16,724 | 3.2% |
| 51600 | Injection procedure for imaging of bladder during voiding | Office | 2023 | 97 | 97 | $97,000 | $10,054 | 10.4% |
| 74455 | Review by radiologist of urinary bladder and urethra images with contrast and after passing urine | Office | 2023 | 88 | 88 | $30,800 | $8,858 | 28.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 29 | 29 | $16,820 | $4,527 | 26.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 379 | 437 | $6,555 | $3,663 | 55.9% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 15 | 15 | $16,845 | $3,255 | 19.3% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 371 | 460 | $161,000 | $3,142 | 2.0% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 14 | 36 | $18,000 | $2,052 | 11.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 19 | $5,510 | $1,256 | 22.8% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 101 | 102 | $20,400 | $1,069 | 5.2% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 12 | 12 | $1,628 | $621.60 | 38.2% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2022 | 285 | 326 | $417,280 | $117,747 | 28.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 578 | 835 | $359,050 | $90,372 | 25.2% |
| 76705 | Limited ultrasound scan of abdomen | Office | 2022 | 690 | 957 | $354,090 | $80,492 | 22.7% |
| 51729 | Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | Office | 2022 | 124 | 124 | $172,360 | $47,137 | 27.3% |
About Dr. Steven Kaplan, MD
Dr. Steven Kaplan, MD is a Urology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932296019.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Kaplan, MD has received a total of $91,479 in payments from pharmaceutical and medical device companies, with $19,379 received in 2024. These payments were reported across 119 transactions from 27 companies. The most common payment nature is "Consulting Fee" ($27,013).
As a Medicare-enrolled provider, Kaplan has provided services to 15,221 Medicare beneficiaries, totaling 18,967 services with total Medicare billing of $2.2M. Data is available for 4 years (2020–2023), covering 102 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location New York, NY
- Active Since 10/09/2006
- Last Updated 09/20/2011
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1932296019
Products in Payments
- MYRBETRIQ (Drug) $18,707
- Noctiva (Drug) $13,412
- APTIVUS (Drug) $9,452
- UROLIFT (Device) $6,900
- GENERAL - BPH (Device) $4,807
- AQUABEAM ROBOTIC SYSTEM (Device) $2,724
- UROLIFT SYSTEM (Device) $1,800
- TOVIAZ (Drug) $1,500
- Watchman (Device) $478.32
- UroLift (Device) $377.91
- Optilume BPH Drug Coated Balloon Catheter (Device) $355.84
- Urolift (Device) $350.00
- AquaBeam Robotic System (Device) $342.79
- GEMTESA (Drug) $323.75
- Rezum (Device) $212.93
- REZUM (Device) $148.07
- General - BPH (Device) $127.48
- ALTIS (Device) $125.77
- General - Therapies (Device) $119.33
- UroCuff (Device) $108.44
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in New York
Mr. Michael Grasso, Md, MD
Urology — Payments: $742,907
Urology $742,907
Robert Valenzuela, Md, MD
Urology — Payments: $642,070
Urology $642,070
Dr. Neil Bander, M.d, M.D
Urology — Payments: $540,525
Urology $540,525
Dr. Benjamin Brucker, Md, MD
Urology — Payments: $454,774
Urology $454,774
Katie Murray, D.o, D.O
Urology — Payments: $367,085
Urology $367,085
Dr. Ketan Badani, M.d, M.D
Urology — Payments: $308,393
Urology $308,393